ClinConnect ClinConnect Logo
Search / Trial NCT06506201

Legs Dysmetria in Total Hip Replacement: Does Hip Approacches and Navigation Decrease the Risk?

Launched by ISTITUTO ORTOPEDICO RIZZOLI · Jul 16, 2024

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how different surgical approaches for total hip replacement may affect a condition called leg dysmetria, which is when the legs are not the same length after surgery. The researchers want to see if using special navigation technology during surgery helps position the hip joint correctly and safely, compared to traditional methods. They will also look at how long the surgery takes and how accurately the surgery is planned.

To be eligible for this trial, participants should be between 50 and 80 years old and have significant pain from hip osteoarthritis, which is a type of joint disease that causes pain and stiffness. Participants will be monitored for a year after their surgery to evaluate how well the procedure worked. It’s important to note that certain health conditions, like uncontrolled diabetes or previous hip surgeries, may exclude individuals from participating. Overall, this study aims to improve surgical outcomes for people undergoing hip replacement surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age between 50 and 80 years;
  • 2. Signs and symptoms of hip osteoarthritis (pain intensity of at least 6 points of visual analogic scale pain - 0-10 scale in the previous week);
  • 3. Radiographic signs of hip osteoarthritis (Grade 3-4 according to Tonnis classification);
  • Exclusion Criteria:
  • 1. Patients unable to express consent;
  • 2. Patients undergoing previous ipsilateral hip surgery;
  • 3. Patients undergoing lower limb surgery to be treated in the previous 12 months;
  • 4. Patients with malignant neoplasms;
  • 5. Patients with rheumatic diseases;
  • 6. Patients with uncontrolled diabetes;
  • 7. Patients with uncontrolled thyroid metabolic disorders;
  • 8. Patients abusing alcoholic beverages, drugs or medications;
  • 9. Body Mass Index \> 35;
  • 10. Pregnant and/or fertile women.
  • 11. Pain intensity less than 6 points in accordance with the visual analogic scale scale.
  • 12. Patients with the presence of excessive deformity resulting from acetabular or femoral head dysplasia
  • 13. Patients who have already undergone total hip arthroplasty surgery on the affected hip.
  • 14. Previous extensive surgery of the reference joint (osteotomy around the hip, open or arthroscopic osteochondroplasty for femoral-acetabular conflict).

About Istituto Ortopedico Rizzoli

Istituto Ortopedico Rizzoli is a renowned orthopedic research and treatment institute based in Bologna, Italy, dedicated to advancing musculoskeletal health through innovative clinical trials and cutting-edge medical practices. With a strong emphasis on research, the institute collaborates with leading experts in orthopedics, rehabilitation, and related fields to develop and evaluate new therapies and surgical techniques. Committed to improving patient outcomes, Istituto Ortopedico Rizzoli not only focuses on high-quality clinical care but also fosters a robust research environment that supports the translation of scientific findings into clinical applications.

Locations

Bologna, , Italy

Patients applied

0 patients applied

Trial Officials

Federico Raggi, MD

Principal Investigator

Isitituto Ortopedico Rizzoli

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported